Patents by Inventor Roslyn Rivkah Isseroff

Roslyn Rivkah Isseroff has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS TO PROMOTE WOUND HEALING
    Publication number: 20190105260
    Abstract: Provided are compositions and methods for the treatment of epithelial wound, particularly chronic or non-healing wounds.
    Type: Application
    Filed: March 21, 2017
    Publication date: April 11, 2019
    Inventors: Roslyn Rivkah Isseroff, Danielle Marie Tartar, Chuong Minh Nguyen, Farzam Gorouhi
  • Methods for in vitro inhibition of fibroblast proliferation
    Patent number: 9861832
    Abstract: Methods for LED generated low-level light therapy (LLLT) in the red, blue, and IR ranges are described to effectively inhibit fibroblast proliferation in vitro without altering viability, and may be used as therapy for the treatment of scars and other proliferative skin diseases.
    Type: Grant
    Filed: March 12, 2014
    Date of Patent: January 9, 2018
    Assignees: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK
    Inventors: Jared Jagdeo, Roslyn Rivkah Isseroff, Andrew Mamalis, Neil Brody, Daniel Siegel, Hadar Lev-Tov
  • COMBINATION THERAPY TO PROMOTE WOUND HEALING
    Publication number: 20160175485
    Abstract: Methods for increasing and/or promoting wound healing, wound re-epithelialization and dermal regeneration of epithelial tissues and cutaneous wounds by administration to a subject of an extracellular matrix scaffold or Scaffold for Dermal Regeneration (SDR) populated with beta adrenergic receptor antagonist pre-conditioned mesenchymal stem cells (MSCs) are provided. Compositions and kits comprising an extracellular matrix scaffold (ECMS) populated with beta adrenergic receptor antagonist pre-conditioned mesenchymal stem cells (MSCs) are also provided.
    Type: Application
    Filed: August 19, 2014
    Publication date: June 23, 2016
    Applicant: The Regents of the University of California
    Inventors: Roslyn Rivkah ISSEROFF, Ravi Krishna Mohan DASU, Sandra RAMIREZ
  • METHODS FOR IN VITRO INHIBITION OF FIBROBLAST PROLIFERATION
    Publication number: 20140277293
    Abstract: Methods for LED generated low-level light therapy (LLLT) in the red, blue, and IR ranges are described to effectively inhibit fibroblast proliferation in vitro without altering viability, and may be used as therapy for the treatment of scars and other proliferative skin diseases.
    Type: Application
    Filed: March 12, 2014
    Publication date: September 18, 2014
    Applicants: THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK, THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Jared Jagdeo, Roslyn Rivkah Isseroff, Andrew Mamalis, Neil Brody, Daniel Siegel, Hadar Lev-Tov
  • Beta-2 Adrenergic Receptor Agonists and Antagonists and Modulation of Wound Healing
    Publication number: 20100215710
    Abstract: Methods for increasing rate of healing of wounds in epithelial tissues by administration of beta-2 adrenergic receptor antagonists to target patients are provided. Methods for decreasing cell growth around implanted devices and methods for decreasing wound contraction by administration of beta-2 adrenergic receptor agonists are also provided. Pharmaceutical compositions and kits including beta-2 adrenergic receptor agonists and antagonists are described, as are devices coated with beta-2 adrenergic receptor agonists.
    Type: Application
    Filed: April 10, 2006
    Publication date: August 26, 2010
    Inventors: Roslyn Rivkah Isseroff, Christine E. Pullar
  • Vitro assay system using a human cell line for testing the effectiveness of anti-papilloma viral agents
    Patent number: 6200745
    Abstract: An in vitro method for testing the effectiveness of antiviral agents is provided. The method allows for screening anti-papillomavirus drugs which can interfere with the early and maintenance stages of papillomavirus infection. The method comprises growing epithelial cells susceptible to infection with papillomavirus in a monolayer system and measuring the effectiveness of various agents present in the growing media to interfere with the growth of the virus. The method is free from interferences caused by the regional variability, since the cell cultures are evenly dispersed monolayers.
    Type: Grant
    Filed: November 19, 1998
    Date of Patent: March 13, 2001
    Assignees: The Penn State Research Foundation, The Regents of the University of California
    Inventors: John W. Kreider, Michael G. Angell, Loyd H. Smith, Margaret Hitchcock, Chris Foster, Roslyn Rivkah Isseroff